{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:30:17Z","timestamp":1787499017471,"version":"build-2736575974"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Thrombotic microangiopathies (TMAs) are a heterogeneous group of disorders characterized by endothelial damage, microvascular thrombosis, thrombocytopenia, and microangiopathic hemolytic anemia. While the initiating triggers may differ\u2014ranging from infections and autoimmune diseases to genetic complement dysregulation\u2014a unifying pathophysiological feature is injury to the vascular endothelium. Recent advances have highlighted the critical role of pro-inflammatory cytokines in mediating endothelial dysfunction, contributing to both the initiation and propagation of thrombotic events in TMAs. Cytokines such as tumor necrosis factor-alpha (TNF-\u03b1), interleukin-6 (IL-6), and interleukin-1\u03b2 (IL-1\u03b2) have been implicated in promoting endothelial activation, increased permeability, leukocyte adhesion, and procoagulant changes. These effects contribute to the loss of vascular integrity and the formation of microthrombi. Moreover, cytokine-mediated inflammation appears to be a common feature across various TMA subtypes, including Shiga toxin-associated hemolytic uremic syndrome (HUS), atypical HUS, thrombotic thrombocytopenic purpura (TTP), and secondary TMAs. The intensity and profile of cytokine involvement may vary, but their pathological influence on endothelial health remains a shared mechanism.<\/jats:p>","DOI":"10.1186\/s10020-025-01331-1","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T09:30:49Z","timestamp":1761298249000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Pathogenic cytokines in thrombotic microangiopathies: molecular insights and therapeutic targets"],"prefix":"10.1186","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4538-0161","authenticated-orcid":false,"given":"Emmanuel Ifeanyi","family":"Obeagu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"issue":"11S","key":"1331_CR1","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1681\/ASN.20233411S1445b","volume":"34","author":"AI Abdelkader","year":"2023","unstructured":"Abdelkader AI, Vilayet S, Bruner E, Achanti A, Budisavljevic MN. Successful management of TAFRO syndrome-related renal thrombotic microangiopathy with interleukin-6 inhibitor: FR-PO143. J Am Soc Nephrol. 2023;34(11S):445\u2013445.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"1331_CR2","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1080\/09537104.2022.2026912","volume":"33","author":"M Al-Tamimi","year":"2022","unstructured":"Al-Tamimi M, Qiao J, Gardiner EE. The utility of platelet activation biomarkers in thrombotic microangiopathies. Platelets. 2022;33(4):503\u201311.","journal-title":"Platelets"},{"issue":"4","key":"1331_CR3","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1093\/ckj\/sfaa195","volume":"14","author":"M Blasco","year":"2021","unstructured":"Blasco M, Guillen E, Quintana LF, Garcia-Herrera A, Pineiro G, Poch E, Carreras E, Campistol JM, Diaz-Ricart M, Palomo M. Thrombotic microangiopathies assessment: mind the complement. Clin Kidney J. 2021;14(4):1055\u201366.","journal-title":"Clin Kidney J"},{"key":"1331_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.811504","volume":"9","author":"M Blasco","year":"2022","unstructured":"Blasco M, Guill\u00e9n-Olmos E, Diaz-Ricart M, Palomo M. Complement mediated endothelial damage in thrombotic microangiopathies. Front Med. 2022;9: 811504.","journal-title":"Front Med"},{"key":"1331_CR5","doi-asserted-by":"publisher","unstructured":"Brocklebank V, Kavanagh D. Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea. Clin Kidney J. 2017;10(5):600- 624. https:\/\/doi.org\/10.1093\/ckj\/sfx081.","DOI":"10.1093\/ckj\/sfx081"},{"key":"1331_CR6","doi-asserted-by":"publisher","unstructured":"Carmona-Rivera C, O'Neil LJ, Patino-Martinez E, Shipman WD, Zhu C, Li QZ, Kerns ML, Barnes LA, Caffrey JA, Kang S, Kaplan MJ, Okoye GA, Byrd AS. Autoantibodies Present in Hidradenitis Suppurativa Correlate with Disease Severity and Promote the Release of Proinflammatory Cytokines in Macrophages. J Invest Dermatol. 2022;142(3 Pt B):924-935. https:\/\/doi.org\/10.1016\/j.jid.2021.07.187","DOI":"10.1016\/j.jid.2021.07.187"},{"issue":"8","key":"1331_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202207155","volume":"10","author":"Z Cai","year":"2023","unstructured":"Cai Z, Chen J, Yu Z, Li H, Liu Z, Deng D, Liu J, Chen C, Zhang C, Ou Z, Chen M. BCAT2 shapes a noninflamed tumor microenvironment and induces resistance to anti-PD-1\/PD-L1 immunotherapy by negatively regulating proinflammatory chemokines and anticancer immunity. Adv Sci. 2023;10(8): 2207155.","journal-title":"Adv Sci"},{"issue":"9","key":"1331_CR8","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.3390\/medicina58091311","volume":"58","author":"JC Chang","year":"2022","unstructured":"Chang JC. Molecular pathogenesis of endotheliopathy and endotheliopathic syndromes, leading to inflammation and microthrombosis, and various hemostatic clinical phenotypes based on \u201ctwo-activation theory of the endothelium\u201d and \u201ctwo-path unifying theory\u201d of hemostasis. Medicina (B Aires). 2022;58(9):1311.","journal-title":"Medicina (B Aires)"},{"issue":"16","key":"1331_CR9","doi-asserted-by":"publisher","first-page":"e021428","DOI":"10.1161\/JAHA.121.021428","volume":"10","author":"JC Chang","year":"2021","unstructured":"Chang JC, Matsubara D, Morgan RW, Diorio C, Nadaraj S, Teachey DT, Bassiri H, Behrens EM, Banerjee A. Skewed cytokine responses rather than the magnitude of the cytokine storm may drive cardiac dysfunction in multisystem inflammatory syndrome in children. J Am Heart Assoc. 2021;10(16):e021428.","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"1331_CR10","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nm1565","volume":"13","author":"SR Clark","year":"2007","unstructured":"Clark SR, Ma AC, Tavener SA, McDonald B, Goodarzi Z, Kelly MM, Patel KD, Chakrabarti S, McAvoy E, Sinclair GD, Keys EM. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med. 2007;13(4):463\u20139.","journal-title":"Nat Med"},{"key":"1331_CR11","doi-asserted-by":"publisher","unstructured":"Coppo P, Schwarzinger M, Buffet M, Wynckel A, Clabault K,Presne C, Poullin P, Malot S, Vanhille P, Azoulay E, Galicier L, Lemiale V, Mira JP, Ridel C, RondeauE, Pourrat J, Girault S, Bordessoule D, Saheb S, Ramakers M, Hamidou M, Vernant JP, Guidet B,Wolf M, Veyradier A; French Reference Center for Thrombotic Microangiopathies. Predictivefeatures of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies:the French TMA reference center experience. PLoS One. 2010;5(4):e10208. https:\/\/doi.org\/10.1371\/journal.pone.0010208","DOI":"10.1371\/journal.pone.0010208"},{"issue":"1","key":"1331_CR12","doi-asserted-by":"publisher","first-page":"a020412","DOI":"10.1101\/cshperspect.a020412","volume":"7","author":"R Daneman","year":"2015","unstructured":"Daneman R, Prat A. The blood\u2013brain barrier. Cold Spring Harb Perspect Biol. 2015;7(1):a020412.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"5","key":"1331_CR13","doi-asserted-by":"publisher","first-page":"4787","DOI":"10.3390\/cimb46050288","volume":"46","author":"P Evangelidis","year":"2024","unstructured":"Evangelidis P, Evangelidis N, Kalmoukos P, Kourti M, Tragiannidis A, Gavriilaki E. Genetic susceptibility in endothelial injury syndromes after hematopoietic cell transplantation and other cellular therapies: climbing a steep hill. Curr Issues Mol Biol. 2024;46(5):4787\u2013802.","journal-title":"Curr Issues Mol Biol"},{"issue":"8","key":"1331_CR14","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41581-021-00424-4","volume":"17","author":"F Fakhouri","year":"2021","unstructured":"Fakhouri F, Fr\u00e9meaux-Bacchi V. Thrombotic microangiopathy in aHUS and beyond: clinical clues from complement genetics. Nat Rev Nephrol. 2021;17(8):543\u201353.","journal-title":"Nat Rev Nephrol"},{"key":"1331_CR15","doi-asserted-by":"publisher","unstructured":"Fakhouri F, Scully M, Prov\u00f4t F, Blasco M, Coppo P, Noris M, Paizis K, Kavanagh D, P\u00e8ne F, Quezada S, Hertig A, Kissling S, O'Brien P, Delmas Y, Alberio L, Winer N, Veyradier A, Cataland S, Fr\u00e9meaux-Bacchi V, Loirat C, Remuzzi G, Tsatsaris V. Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group. Blood. 2020;136(19):2103-2117. https:\/\/doi.org\/10.1182\/blood.2020005221.","DOI":"10.1182\/blood.2020005221"},{"issue":"10095","key":"1331_CR16","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0140-6736(17)30062-4","volume":"390","author":"F Fakhouri","year":"2017","unstructured":"Fakhouri F, Zuber J, Fr\u00e9meaux-Bacchi V, Loirat C. Haemolytic uraemic syndrome. Lancet. 2017;390(10095):681\u201396.","journal-title":"Lancet"},{"key":"1331_CR17","doi-asserted-by":"publisher","first-page":"780107","DOI":"10.3389\/fimmu.2021.780107","volume":"12","author":"EJ Filippone","year":"2021","unstructured":"Filippone EJ, Newman ED, Li L, Gulati R, Farber JL. Thrombotic microangiopathy, an unusual form of monoclonal gammopathy of renal significance: report of 3 cases and literature review. Front Immunol. 2021;12:780107.","journal-title":"Front Immunol"},{"issue":"10","key":"1331_CR18","first-page":"8599","volume":"30","author":"C Font","year":"2022","unstructured":"Font C, de Herreros MG, Tsoukalas N, Brito-Dellan N, Esp\u00f3sito F, Escalante C, Oo TH. Thrombotic microangiopathy (TMA) in adult patients with solid tumors: a challenging complication in the era of emerging anticancer therapies. Support Care Cancer. 2022;30(10):8599\u2013609.","journal-title":"Support Care Cancer"},{"issue":"7","key":"1331_CR19","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1056\/NEJMra1312353","volume":"371","author":"JN George","year":"2014","unstructured":"George JN, Nester CM. Syndromes of thrombotic microangiopathy. N Engl J Med. 2014;371(7):654\u201366.","journal-title":"N Engl J Med"},{"issue":"3","key":"1331_CR20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/17474086.2023.2162501","volume":"16","author":"M Guo","year":"2023","unstructured":"Guo M, Qi J, Hou Q, Li X, Han Y. Risk factors for transplant-associated thrombotic microangiopathy (TA-TMA): a systematic review and meta-analysis. Expert Rev Hematol. 2023;16(3):191\u2013203.","journal-title":"Expert Rev Hematol"},{"key":"1331_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.566678","volume":"8","author":"N Henry","year":"2021","unstructured":"Henry N, Mellaza C, Fage N, Beloncle F, Genevieve F, Legendre G, Orvain C, Garnier AS, Cousin M, Besson V, Subra JF. Retrospective and systematic analysis of causes and outcomes of thrombotic microangiopathies in routine clinical practice: an 11-year study. Front Med. 2021;8: 566678.","journal-title":"Front Med"},{"key":"1331_CR22","doi-asserted-by":"publisher","unstructured":"Hunt R, Yalamanoglu A, Tumlin J,Schiller T, Baek JH, Wu A, Fogo AB, Yang H, Wong E, Miller P, Buehler PW, Kimchi-Sarfaty C. Amechanistic investigation of thrombotic microangiopathy associated with IV abuse of Opana ER.Blood. 2017;129(7):896-905. https:\/\/doi.org\/10.1182\/blood-2016-08-736579.","DOI":"10.1182\/blood-2016-08-736579"},{"issue":"1","key":"1331_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02256-3","volume":"24","author":"DY Hyeon","year":"2025","unstructured":"Hyeon DY, Nam D, Shin HJ, Jeong J, Jung E, Cho SY, Shin DH, Ku JL, Baek HJ, Yoo CW, Hong EK. Proteogenomic characterization of molecular and cellular targets for treatment-resistant subtypes in locally advanced cervical cancers. Mol Cancer. 2025;24(1): 77.","journal-title":"Mol Cancer"},{"issue":"6","key":"1331_CR24","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3899\/jrheum.220752","volume":"50","author":"A Java","year":"2023","unstructured":"Java A, Kim AH. The role of complement in autoimmune disease-associated thrombotic microangiopathy and the potential for therapeutics. J Rheumatol. 2023;50(6):730\u201340.","journal-title":"J Rheumatol"},{"key":"1331_CR25","doi-asserted-by":"publisher","unstructured":"Jodele S, Davies SM,Lane A, Khoury J, Dandoy C, Goebel J, Myers K, Grimley M, Bleesing J, El-Bietar J, Wallace G,Chima RS, Paff Z, Laskin BL. Diagnostic and risk criteria for HSCT-associated thromboticmicroangiopathy: a study in children and young adults. Blood. 2014;124(4):645-53. https:\/\/doi.org\/10.1182\/blood-2014-03-564997","DOI":"10.1182\/blood-2014-03-564997"},{"issue":"13","key":"1331_CR26","first-page":"1049","volume":"135","author":"S Jodele","year":"2020","unstructured":"Jodele S, Dandoy CE, Lane A, Laskin BL, Teusink-Cross A, Myers KC, Wallace G, Nelson A, Bleesing J, Chima RS, Hirsch R. Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab. Blood J Am Soc Hematol. 2020;135(13):1049\u201357.","journal-title":"Blood J Am Soc Hematol"},{"key":"1331_CR27","doi-asserted-by":"publisher","unstructured":"Keepers GA, Fochtmann LJ, Anzia JM, Benjamin S, Lyness JM, Mojtabai R, Servis M, WalaszekA, Buckley P, Lenzenweger MF, Young AS, Degenhardt A, Hong SH; (Systematic Review). The American Psychiatric Association Practice Guideline for the Treatment of Patients with Schizophrenia. Am J Psychiatry. 2020;177(9):868-872. https:\/\/doi.org\/10.1176\/appi.ajp.2020.177901.","DOI":"10.1176\/appi.ajp.2020.177901"},{"issue":"14","key":"1331_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241411287","volume":"24","author":"CY Kei","year":"2023","unstructured":"Kei CY, Singh K, Dautov RF, Nguyen TH, Chirkov YY, Horowitz JD. Coronary \u201cmicrovascular dysfunction\u201d: evolving understanding of pathophysiology, clinical implications, and potential therapeutics. Int J Mol Sci. 2023;24(14): 11287.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"1331_CR29","doi-asserted-by":"publisher","first-page":"524","DOI":"10.23876\/j.krcp.22.010","volume":"41","author":"YJ Kim","year":"2022","unstructured":"Kim YJ. A new pathological perspective on thrombotic microangiopathy. Kidney Res Clin Pract. 2022;41(5):524.","journal-title":"Kidney Res Clin Pract"},{"issue":"1","key":"1331_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41572-020-0204-y","volume":"6","author":"AR Kitching","year":"2020","unstructured":"Kitching AR, Anders HJ, Basu N, Brouwer E, Gordon J, Jayne D, et al. ANCA-associated vasculitis. Nat Rev Dis Primers. 2020;6(1):71.https:\/\/doi.org\/10.1038\/s41572-020-0204-y","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"1331_CR31","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.3390\/ijms23042106","volume":"23","author":"OM Koper-Lenkiewicz","year":"2022","unstructured":"Koper-Lenkiewicz OM, Sutkowska K, Wawrusiewicz-Kurylonek N, Kowalewska E, Matowicka-Karna J. Proinflammatory cytokines (IL-1,-6,-8,-15,-17,-18,-23, TNF-\u03b1) single nucleotide polymorphisms in rheumatoid arthritis\u2014a literature review. Int J Mol Sci. 2022;23(4): 2106.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1331_CR32","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/art.42681","volume":"76","author":"J Leisring","year":"2024","unstructured":"Leisring J, Brodsky SV, Parikh SV. Clinical evaluation and management of thrombotic microangiopathy. Arthritis Rheumatol. 2024;76(2):153\u201365.","journal-title":"Arthritis Rheumatol"},{"key":"1331_CR33","doi-asserted-by":"publisher","first-page":"838","DOI":"10.3389\/fimmu.2018.00838","volume":"9","author":"A Leligdowicz","year":"2018","unstructured":"Leligdowicz A, Richard-Greenblatt M, Wright J, Crowley VM, Kain KC. Endothelial activation: the Ang\/Tie axis in sepsis. Front Immunol. 2018;9:838 (PMID: 27782324).","journal-title":"Front Immunol"},{"key":"1331_CR34","first-page":"234","volume":"133","author":"WC Liles","year":"2023","unstructured":"Liles WC. Microvascular endothelial activation\/dysfunction and dysregulation of the angiopoietin-TIE2 system in the pathogenesis of life-threatening infections. Trans Am Clin Climatol Assoc. 2023;133:234.","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"1331_CR35","doi-asserted-by":"publisher","first-page":"6719","DOI":"10.2147\/JIR.S520726","volume":"31","author":"Y Liu","year":"2025","unstructured":"Liu Y, Zhao W, Huang Q, Wan L, Ren Z, Zhang B, Han C, Yang J, Zhang H, Zhang J. Advances in research on the release of von Willebrand factor from endothelial cells through the membrane attack complex C5b\u20139 in sepsis. J Inflamm Res. 2025;31:6719\u201333.","journal-title":"J Inflamm Res"},{"issue":"3","key":"1331_CR36","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.kint.2015.10.010","volume":"89","author":"C Loirat","year":"2016","unstructured":"Loirat C, Fakhouri F, Ariceta G, Besbas N, Bitzan M, Bjerre A, et al. An international consensus approach to the management of atypical hemolytic uremic syndrome in children. Kidney Int. 2016;89(3):539\u201347.","journal-title":"Kidney Int"},{"issue":"1","key":"1331_CR37","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nmeth.1543","volume":"8","author":"MR Looney","year":"2011","unstructured":"Looney MR, Thornton EE, Sen D, Lamm WJ, Glenny RW, Krummel MF. Stabilized imaging of immune surveillance in the mouse lung. Nat Methods. 2011;8(1):91\u20136.","journal-title":"Nat Methods"},{"issue":"18","key":"1331_CR38","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.2174\/1381612827666210303143442","volume":"27","author":"LJ Malhab","year":"2021","unstructured":"Malhab LJ, Saber-Ayad MM, Al-Hakm R, Nair VA, Paliogiannis P, Pintus G, Abdel-Rahman WM. Chronic inflammation and cancer: the role of endothelial dysfunction and vascular inflammation. Curr Pharm Des. 2021;27(18):2156\u201369.","journal-title":"Curr Pharm Des"},{"issue":"2","key":"1331_CR39","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41375-024-02147-4","volume":"38","author":"HK Mandhair","year":"2024","unstructured":"Mandhair HK, Radpour R, Westerhuis M, Banz Y, Humbert M, Arambasic M, Dengjel J, Davies A, Tschan MP, Novak U. Analysis of autophagy in DLBCL reveals subtype-specific differences and the preferential targeting of ULK1 inhibition in GCB-DLBCL provides a rationale as a new therapeutic approach. Leukemia. 2024;38(2):424\u20139.","journal-title":"Leukemia"},{"key":"1331_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1088031","volume":"13","author":"T Mazzierli","year":"2023","unstructured":"Mazzierli T, Allegretta F, Maffini E, Allinovi M. Drug-induced thrombotic microangiopathy: an updated review of causative drugs, pathophysiology, and management. Front Pharmacol. 2023;13: 1088031.","journal-title":"Front Pharmacol"},{"key":"1331_CR41","doi-asserted-by":"publisher","first-page":"205435812110087","DOI":"10.1177\/20543581211008707","volume":"8","author":"PA McFarlane","year":"2021","unstructured":"McFarlane PA, Bitzan M, Broome C, Baran D, Garland J, Girard LP, Grewal K, Lapeyraque AL, Patriquin CJ, Pavenski K, Licht C. Making the correct diagnosis in thrombotic microangiopathy: a narrative review. Can J Kidney Health Dis. 2021;8:20543581211008708.","journal-title":"Can J Kidney Health Dis"},{"key":"1331_CR42","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.jpeds.2021.04.004","volume":"235","author":"F Minoia","year":"2021","unstructured":"Minoia F, Tibaldi J, Muratore V, Gallizzi R, Bracaglia C, Arduini A, Comak E, Vougiouka O, Trauzeddel R, Filocamo G, Mastrangelo A. Thrombotic microangiopathy associated with macrophage activation syndrome: a multinational study of 23 patients. J Pediatr. 2021;235:196\u2013202.","journal-title":"J Pediatr"},{"issue":"1","key":"1331_CR43","doi-asserted-by":"publisher","first-page":"90277","DOI":"10.5500\/wjt.v14.i1.90277","volume":"14","author":"M Mubarak","year":"2024","unstructured":"Mubarak M, Raza A, Rashid R, Sapna F, Shakeel S. Thrombotic microangiopathy after kidney transplantation: expanding etiologic and pathogenetic spectra. World J Transplant. 2024;14(1):90277.","journal-title":"World J Transplant"},{"key":"1331_CR44","doi-asserted-by":"publisher","unstructured":"Nester CM, Barbour T, de Cordoba SR, Dragon-Durey MA, Fremeaux-Bacchi V, Goodship TH, Kavanagh D, Noris M, Pickering M, Sanchez-Corral P, Skerka C, Zipfel P, Smith RJ. Atypical aHUS: State of the art. Mol Immunol. 2015;67(1):31-42. https:\/\/doi.org\/10.1016\/j.molimm.2015.03.246","DOI":"10.1016\/j.molimm.2015.03.246"},{"issue":"17","key":"1331_CR45","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1056\/NEJMra0902814","volume":"361","author":"M Noris","year":"2009","unstructured":"Noris M, Remuzzi G. Atypical hemolytic\u2013uremic syndrome. N Engl J Med. 2009;361(17):1676\u201387.","journal-title":"N Engl J Med"},{"issue":"6","key":"1331_CR46","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.semnephrol.2013.08.001","volume":"33","author":"M Noris","year":"2013","unstructured":"Noris M, Remuzzi G. Overview of complement activation and regulation. Semin Nephrol. 2013;33(6):479\u201392.","journal-title":"Semin Nephrol"},{"issue":"21","key":"1331_CR47","doi-asserted-by":"publisher","first-page":"15484","DOI":"10.1016\/S0021-9258(18)82282-7","volume":"268","author":"TG Obrig","year":"1993","unstructured":"Obrig TG, Louise CB, Lingwood CA, Boyd B, Barley-Maloney L, Daniel TO. Endothelial heterogeneity in Shiga toxin receptors and responses. J Biol Chem. 1993;268(21):15484\u20138.","journal-title":"J Biol Chem"},{"issue":"1","key":"1331_CR48","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ekir.2020.10.009","volume":"6","author":"LM Palma","year":"2021","unstructured":"Palma LM, Sridharan M, Sethi S. Complement in secondary thrombotic microangiopathy. Kidney Int Rep. 2021;6(1):11\u201323.","journal-title":"Kidney Int Rep"},{"issue":"12","key":"1331_CR49","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.medcle.2020.12.025","volume":"156","author":"JA Paramo","year":"2021","unstructured":"Paramo JA. Microvascular thrombosis and clinical implications. Med Cl\u00edn (English Edition). 2021;156(12):609\u201314.","journal-title":"Med Cl\u00edn (English Edition)"},{"key":"1331_CR50","doi-asserted-by":"publisher","unstructured":"Ramgopal A, Sridar S, Dalal J,Kalpatthi R. Thrombotic Microangiopathy: Multi-Institutional Review of Pediatric Patients WhoUnderwent HSCT. J Pers Med. 2021;11(6):467. https:\/\/doi.org\/10.3390\/jpm11060467","DOI":"10.3390\/jpm11060467"},{"key":"1331_CR51","doi-asserted-by":"crossref","unstructured":"Riedl Khursigara M, Benoit S, Patriquin CJ, Lemaire M, Licht C. Thrombotic Thrombocytopenic Purpura, Atypical Hemolytic Uremic Syndrome, and Spectrum of Thrombotic Microangiopathy. InPediatric Nephrology 2022: 595\u2013635. Cham: Springer International Publishing.","DOI":"10.1007\/978-3-030-52719-8_43"},{"issue":"5","key":"1331_CR52","doi-asserted-by":"publisher","first-page":"F947","DOI":"10.1152\/ajprenal.90601.2008","volume":"296","author":"SC Satchell","year":"2009","unstructured":"Satchell SC, Braet F. Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier. Am J Physiol Renal Physiol. 2009;296(5):F947-956.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"1331_CR53","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1038\/s41467-022-29164-0","volume":"13","author":"G Song","year":"2022","unstructured":"Song G, Shi Y, Meng L, Ma J, Huang S, Zhang J, Wu Y, Li J, Lin Y, Yang S, Rao D. Single-cell transcriptomic analysis suggests two molecularly distinct subtypes of intrahepatic cholangiocarcinoma. Nat Commun. 2022;13(1):1642.","journal-title":"Nat Commun"},{"key":"1331_CR54","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/ijlh.13954","volume":"44","author":"GL Thompson","year":"2022","unstructured":"Thompson GL, Kavanagh D. Diagnosis and treatment of thrombotic microangiopathy. Int J Lab Hematol. 2022;44:101\u201313.","journal-title":"Int J Lab Hematol"},{"key":"1331_CR55","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1016\/j.csbj.2024.04.056","volume":"23","author":"S Tian","year":"2024","unstructured":"Tian S, Luo M, Liao X, Zhang L, Zhang J, Zhang J, Li Y, Qin J, Luan X, Zhang W. Integrated immunogenomic analysis of single-cell and bulk profiling reveals novel tumor antigens and subtype-specific therapeutic agents in lung adenocarcinoma. Comput Struct Biotechnol J. 2024;23:1897\u2013911.","journal-title":"Comput Struct Biotechnol J"},{"issue":"14","key":"1331_CR56","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.3390\/jcm10143034","volume":"10","author":"SA Timmermans","year":"2021","unstructured":"Timmermans SA, van Paassen P. The syndromes of thrombotic microangiopathy: a critical appraisal on complement dysregulation. J Clin Med. 2021;10(14):3034.","journal-title":"J Clin Med"},{"key":"1331_CR65","doi-asserted-by":"publisher","unstructured":"Uemura M, Fujimura Y, Ko S, Matsumoto M, Nakajima Y, Fukui H. Determination of ADAMTS13 andIts Clinical Significance for ADAMTS13 Supplementation Therapy to Improve the Survival of Patientswith Decompensated Liver Cirrhosis. Int J Hepatol. 2011; 2011:759047. https:\/\/doi.org\/10.4061\/2011\/759047.","DOI":"10.4061\/2011\/759047"},{"issue":"4","key":"1331_CR57","doi-asserted-by":"publisher","first-page":"100690","DOI":"10.1016\/j.modpat.2024.100690","volume":"38","author":"DP van Doorn","year":"2025","unstructured":"van Doorn DP, Tobal R, Abdul-Hamid MA, van Paassen P, Timmermans SA. Etiology and outcomes of kidney-limited and systemic thrombotic microangiopathy. Mod Pathol. 2025;38(4):100690.","journal-title":"Mod Pathol"},{"issue":"16","key":"1331_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25169055","volume":"25","author":"A Vorobev","year":"2024","unstructured":"Vorobev A, Bitsadze V, Yagubova F, Khizroeva J, Solopova A, Tretyakova M, Gashimova N, Grigoreva K, Einullaeva S, Drozhzhina M, Hajiyeva A. The phenomenon of thrombotic microangiopathy in cancer patients. Int J Mol Sci. 2024;25(16): 9055.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1331_CR59","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1182\/blood.2023021949","volume":"144","author":"K Watanabe-Kusunoki","year":"2024","unstructured":"Watanabe-Kusunoki K, Li C, Bandeira Honda TS, Zhao D, Kusunoki Y, Ku J, Long H, Klaus M, Han C, Braun A, Mammadova-Bach E. Gasdermin D drives focal crystalline thrombotic microangiopathy by accelerating immunothrombosis and necroinflammation. Blood. 2024;144(3):308\u201322.","journal-title":"Blood"},{"issue":"4","key":"1331_CR60","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/s41409-022-01581-1","volume":"57","author":"LP Yang","year":"2022","unstructured":"Yang LP, Zhao P, Wu YJ, Fu HX, He Y, Mo XD, Lv M, Wang FR, Yan CH, Chen YH, Chang YJ. Treatment outcome and efficacy of therapeutic plasma exchange for transplant-associated thrombotic microangiopathy in a large real-world cohort study. Bone Marrow Transplant. 2022;57(4):554\u201361.","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"1331_CR61","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1038\/s41409-021-01283-0","volume":"56","author":"JA Young","year":"2021","unstructured":"Young JA, Pallas CR, Knovich MA. Transplant-associated thrombotic microangiopathy: theoretical considerations and a practical approach to an unrefined diagnosis. Bone Marrow Transplant. 2021;56(8):1805\u201317.","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"1331_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25021082","volume":"25","author":"H Zhang","year":"2024","unstructured":"Zhang H, Dhalla NS. The role of pro-inflammatory cytokines in the pathogenesis of cardiovascular disease. Int J Mol Sci. 2024;25(2): 1082.","journal-title":"Int J Mol Sci"},{"key":"1331_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2025.109376","volume":"4","author":"W Zhou","year":"2025","unstructured":"Zhou W, Qin X, Xu H, Pan J. Genetic insights into cytokine-thrombosis cross-talk: an integrated multi-omics network analysis. Thromb Res. 2025;4: 109376.","journal-title":"Thromb Res"},{"issue":"2","key":"1331_CR64","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1681\/ASN.2019050515","volume":"31","author":"PF Zipfel","year":"2020","unstructured":"Zipfel PF, Wiech T, Stea ED, Skerka C. CFHR gene variations provide insights in the pathogenesis of the kidney diseases atypical hemolytic uremic syndrome and C3 glomerulopathy. J Am Soc Nephrol. 2020;31(2):241\u201356.","journal-title":"J Am Soc Nephrol"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01331-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-025-01331-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01331-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T10:02:38Z","timestamp":1761300158000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-025-01331-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1331"],"URL":"https:\/\/doi.org\/10.1186\/s10020-025-01331-1","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"8 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable as this is a narrative review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"316"}}